These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 7486717)

  • 1. [Local cutaneous necrosis after injection of interferon beta].
    Bérard F; Canillot S; Balme B; Perrot H
    Ann Dermatol Venereol; 1995; 122(3):105-7. PubMed ID: 7486717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severe local skin reactions to interferon beta-1b in multiple sclerosis-improvement by deep subcutaneous injection.
    Nakamura Y; Kawachi Y; Furuta J; Otsuka F
    Eur J Dermatol; 2008; 18(5):579-82. PubMed ID: 18693165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lobular panniculitis at the site of subcutaneous interferon beta injections for the treatment of multiple sclerosis can histologically mimic pancreatic panniculitis. A study of 12 cases.
    Ball NJ; Cowan BJ; Hashimoto SA
    J Cutan Pathol; 2009 Mar; 36(3):331-7. PubMed ID: 19032383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Embolia cutis medicamentosa following interferon beta injection.
    Koontz D; Alshekhlee A
    Mult Scler; 2007 Nov; 13(9):1203-4. PubMed ID: 17967846
    [No Abstract]   [Full Text] [Related]  

  • 5. [Alpha interferon-induced eczema in atopic patients infected by hepatitis C virus: 4 case reports].
    Berger L; Descamps V; Marck Y; Dehen L; Grossin M; Crickx B; Marcellin P; Belaich S
    Ann Dermatol Venereol; 2000 Jan; 127(1):51-5. PubMed ID: 10717563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dermal fibrosis and cutaneous necrosis after recombinant interferon-beta1a injection in a multiple sclerosis patient.
    Ozden MG; Erel A; Erdem O; Oztas MO
    J Eur Acad Dermatol Venereol; 2005 Jan; 19(1):112-3. PubMed ID: 15649205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A pilot study of combination therapy with initial high-dose interferon and amantadine hydrochloride for patients with chronic hepatitis C with the genotype 1b virus.
    Uyama H; Enomoto H; Kishima Y; Yamamoto M; Yoshida K; Okuda Y; Hirotani T; Kuroda T; Ito H; Matsuda M; Terabayashi M; Noguchi S; Kawase I; Nakamura H
    Hepatogastroenterology; 2003; 50(54):2112-6. PubMed ID: 14696476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pilot study on the safety and efficacy of intravenous natural beta-interferon therapy in patients with chronic hepatitis C unresponsive to alpha-interferon.
    Mazzoran L; Grassi G; Giacca M; Gerini U; Baracetti S; Fanni-Canelles M; Zorat F; Pozzato G
    Ital J Gastroenterol Hepatol; 1997 Aug; 29(4):338-42. PubMed ID: 9476188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Twice-a-day versus once-a-day interferon-beta therapy in chronic hepatitis C.
    Kaito M; Yasui-Kawamura N; Iwasa M; Kobayashi Y; Nakagawa N; Fujita N; Ikoma J; Gabazza EC; Watanabe S; Adachi Y
    Hepatogastroenterology; 2003; 50(51):775-8. PubMed ID: 12828083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case report of interferon beta monotherapy for high hepatitis C viral load in dialysis patients.
    Nakajima F; Fukii M; Kitamura T; Sakaida A; Sakaguchi M; Oka H; Morimoto S; Masaki H; Yamahara H; Shibahara N; Inoue T
    Ther Apher Dial; 2007 Aug; 11(4):306-8. PubMed ID: 17661838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Aseptic skin necrosis after subcutaneous injection of alpha interferon].
    Rasokat H; Bendick C; Wemmer U; Steigleder GK
    Dtsch Med Wochenschr; 1989 Mar; 114(12):458-60. PubMed ID: 2924699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural beta interferon in acute type-C hepatitis patients: a randomized controlled trial.
    Calleri G; Colombatto P; Gozzelino M; Chieppa F; Romano P; Delmastro B; Macor A; Cariti G; Brunetto MR; Grillone W; Bonino F
    Ital J Gastroenterol Hepatol; 1998 Apr; 30(2):181-4. PubMed ID: 9675655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon treatment of porphyria cutanea tarda associated with chronic hepatitis type C.
    Okano J; Horie Y; Kawasaki H; Kondo M
    Hepatogastroenterology; 1997; 44(14):525-8. PubMed ID: 9164531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cutaneous reactions following subcutaneous beta-interferon-1b injection.
    Ohata U; Hara H; Yoshitake M; Terui T
    J Dermatol; 2010 Feb; 37(2):179-81. PubMed ID: 20175855
    [No Abstract]   [Full Text] [Related]  

  • 15. Predictors of the efficacy of intravenous natural interferon-beta treatment in chronic hepatitis C.
    Fukutomi T; Fukutomi M; Iwao M; Watanabe H; Tanabe Y; Hiroshige K; Kinukawa N; Nakamuta M; Nawata H
    Med Sci Monit; 2000; 6(4):692-8. PubMed ID: 11208393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Thyroid dysfunction in patients with chronic hepatitis C pre and post treatment with interferon].
    Martín-Vivaldi R; Nogueras F; Quintero D; Espinosa MD; López de Hierro M; Suárez JF; González A
    Rev Esp Enferm Dig; 1996 Jul; 88(7):480-4. PubMed ID: 8924326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Panniculitis after subcutaneous injection of interferon beta in a multiple sclerosis patient.
    Heinzerling L; Dummer R; Burg G; Schmid-Grendelmeier P
    Eur J Dermatol; 2002; 12(2):194-7. PubMed ID: 11872423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mono-arthritis following intensified interferon beta therapy for chronic hepatitis C.
    Murata K; Shiraki K; Takase K; Nakano T; Tameda Y
    Hepatogastroenterology; 2002; 49(47):1418-9. PubMed ID: 12239955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrent injection site reactions from interferon beta 1-b.
    Samuel L; Lowenstein EJ
    J Drugs Dermatol; 2006 Apr; 5(4):366-7. PubMed ID: 16673806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Peripheral neuropathy during a second cycle of treatment with high doses of interferon-alpha in a patient with hepatitis C, and a review of the literature].
    Téllez-Zenteno JF; Negrete-Pulido O; Nuñez M; Estañol-Vidal B; García-Ramos G
    Rev Neurol; 2002 Oct 1-15; 35(7):644-6. PubMed ID: 12389150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.